Lucintel Blog: Infectious diseases is expected to remain the largest segment in the global in-vitro diagnostics market

Wednesday, May 10, 2023

Infectious diseases is expected to remain the largest segment in the global in-vitro diagnostics market

An exciting new study from the team of Lucintel found that in-vitro diagnostics market is expected to reach $127.3 billion by 2028 with a CAGR of 5%. There are significant money making opportunities available in this market and companies planning to enter this market need to differentiate in order to maximize their return on investment.

Download Brochure of this report by clicking on https://www.lucintel.com/in-vitro-diagnostics-market.aspx.

The in-vitro diagnostics market is segmented based on product, application, technology, end use industry, and region. In this market, infectious diseases is expected to remain the largest application, and laboratories segment is expected to remain the largest end use industry. Players can benefit from the available opportunities like presence of well-established healthcare infrastructure, rising geriatric population, and an increase in healthcare expenditure.

Abbott, bioMérieux, Bio-Rad, Siemens Healthineers, and Qiagen are some of the major players profiled in this 150 page report.

Request Sample Pages by clicking on https://www.lucintel.com/in-vitro-diagnostics-market.aspx.

Some of the Key Questions answered in this exclusive report are:

Q.1 What are some of the most promising, high-growth opportunities for the in-vitro diagnostics market by product (instruments, reagents, and services), application (infectious diseases, diabetes, oncology, cardiology, nephrology, autoimmune diseases, drug testing, others), technology (immunoassay, hematology, clinical chemistry), molecular diagnostics, coagulation, microbiology, and others), end use industry (hospitals, laboratories, home care, and others), and region?

Q.2 Which segments will grow at a faster pace and why?

Q.3 What are the business risks and threats to the in-vitro diagnostics market?

Q.4 What are some changing demands of customers in the in-vitro diagnostics market?

Q.5 What are the new developments in the in-vitro diagnostics market? Which companies are leading these developments?

Q.6 What strategic initiatives are being implemented by key players for business growth?

Q.7 What are some of the competitive products and processes in this in-vitro diagnostics area and how big of a threat do they pose for loss of market share via product substitution?

Q.8 What M&A activity has occurred in the last 5 years in this in-vitro diagnostics market?

This unique report from Lucintel will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056

Related reports

Cryostat Market:

For more details click here https://www.lucintel.com/cryostat-market.aspx

Medical Equipment Maintenance Market:

For more details click here https://www.lucintel.com/medical-equipment-maintenance-market.aspx

Intensive Care Unit Equipment Market:

For more details click here https://www.lucintel.com/intensive-care-unit-equipment-market.aspx

Pharmaceutical Drug Delivery Market:

For more details click here https://www.lucintel.com/needle-market.aspx

Metabolomics Market:

For more details click here https://www.lucintel.com/metabolomics-market.aspx